Protein Kinase C Induces Motility of Breast Cancers by Upregulating Secretion of Urokinase-Type Plasminogen Activator through Activation of AP-1 and NF-κB
- 1 January 2002
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 290 (1), 552-557
- https://doi.org/10.1006/bbrc.2001.6225
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- AP-1 blockade inhibits the growth of normal and malignant breast cellsOncogene, 2001
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Enhancement of the Migration of Metastatic Human Breast Cancer Cells by Phosphatidic AcidBiochemical and Biophysical Research Communications, 2000
- Tip60 Interacts with Human Interleukin-9 Receptor α-ChainBiochemical and Biophysical Research Communications, 1999
- Regulation of Motility and Protease Expression in PKC-Mediated Induction of MCF-7 Breast Cancer Cell InvasivenessExperimental Cell Research, 1999
- uPA, uPAR, PAI-I: Key intersection of proteolytic, adhesive and chemotacfic highways?Immunology Today, 1997
- Matrix MetalloproteinasesDrugs & Aging, 1997
- Elevation of protein kinase A and protein kinase C activities in malignant as compared with normal human breast tissueEuropean Journal Of Cancer, 1996
- Tumor-Associated Urokinase-Type Plasminogen Activator: Biological and Clinical SignificanceBiological Chemistry Hoppe-Seyler, 1992
- UROKINASE-TYPE PLASMINOGEN ACTIVATOR ANTIGEN AND EARLY RELAPSE IN BREAST CANCERThe Lancet, 1989